FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula I,
or a pharmaceutically acceptable salt thereof, also to a pharmaceutical composition, methods of treatment and modulation, due to the effect on the receptor of follicle-stimulating hormone.
EFFECT: compounds of this invention, and pharmaceutically acceptable compositions thereof, are effective as modulators of FSHR.
19 cl, 50 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2734390C2 |
| HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS | 2010 |
|
RU2615130C2 |
| SUBSTITUTED PYRAZOLO-QUINAZOLINE DERIVATIVES AS KINASE INHIBITORS | 2011 |
|
RU2652638C2 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2014 |
|
RU2681849C2 |
| HALOGEN SUBSTITUTED HETEROCYCLIC COMPOUND | 2013 |
|
RU2649398C2 |
| HALOGEN-SUBSTITUTED HETEROCYCLIC COMPOUND | 2013 |
|
RU2756506C2 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2711502C2 |
| HETEROARYL COMPOUNDS AS TKB INHIBITORS AND USE THEREOF | 2015 |
|
RU2742122C2 |
| MONOACYLGLYCEROL LIPASE MODULATORS | 2019 |
|
RU2797323C2 |
| SERIN / TREONIN KINASE INHIBITORS FOR TREATING OF HYPEROPLIFERATIVE DISEASES | 2013 |
|
RU2644947C2 |
